Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | CYP2A13 | Q16696 | 3/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18360630 | 0.86 | KDM4E (0.60) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL15081986 | 0.82 | KDM4E (0.52) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL8551996 | 0.82 | CXCR4 (0.69) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| Hydrochloric Acid SCHEMBL3105464 | 0.80 | KDM4E (0.61) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL18360700 | 0.79 | KDM4E (0.69) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL11360607 | 0.78 | SIGMAR1 (0.85) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL7372983 | 0.77 | KDM4E (1.00) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| SCHEMBL20557039 | 0.77 | KDM4E (0.58) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| Phosphoric Acid SCHEMBL3110216 | 0.77 | KDM4E (0.54) | KDM4EHTTSIGMAR1CYP2A13CXCR4 | |
| Sulfuric Acid SCHEMBL3102231 | 0.77 | KDM4E (0.54) | KDM4EHTTSIGMAR1CYP2A13CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100274003-A1 | ACID ADDITION SALTS OF SYNTHETIC INTERMEDIATES FOR CARBAPENEM ANTIBIOTICS AND PROCESSES FOR PREPARING THE SAME | Kukje Pharm Ind co. Ltd (KR) | 2010-10-28 | — | — | US | disclosed |
| EP-2188287-A2 | ACID ADDITION SALTS OF SYNTHETIC INTERMEDIATES FOR CARBAPENEM ANTIBIOTICS AND PROCESSES FOR PREPARING THE SAME | Kukje Pharm. Ind. Co., Ltd. (KR) | 2010-05-26 | — | — | EP | disclosed |
| WO-2009038328-A2 | ACID ADDITION SALTS OF SYNTHETIC INTERMEDIATES FOR CARBAPENEM ANTIBIOTICS AND PROCESSES FOR PREPARING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2009-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274003-A1 | ACID ADDITION SALTS OF SYNTHETIC INTERMEDIATES FOR CARBAPENEM ANTIBIOTICS AND PROCESSES FOR PREPARING THE SAME | SLC7A5, SI, ADSL | KDM4E 871/4885HTT 4604/4885SIGMAR1 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.